Ritholtz Wealth Management Has $244,000 Stock Position in Smith & Nephew plc (NYSE:SNN)

Ritholtz Wealth Management decreased its holdings in shares of Smith & Nephew plc (NYSE:SNN) by 46.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 6,241 shares of the medical equipment provider’s stock after selling 5,333 shares during the quarter. Ritholtz Wealth Management’s holdings in Smith & Nephew were worth $244,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Shine Investment Advisory Services Inc. lifted its position in Smith & Nephew by 5.8% during the 2nd quarter. Shine Investment Advisory Services Inc. now owns 4,690 shares of the medical equipment provider’s stock valued at $179,000 after purchasing an additional 258 shares during the period. Assetmark Inc. lifted its position in Smith & Nephew by 0.3% during the 2nd quarter. Assetmark Inc. now owns 81,492 shares of the medical equipment provider’s stock valued at $3,182,000 after purchasing an additional 263 shares during the period. Patriot Financial Group Insurance Agency LLC lifted its position in Smith & Nephew by 91.8% during the 2nd quarter. Patriot Financial Group Insurance Agency LLC now owns 723 shares of the medical equipment provider’s stock valued at $28,000 after purchasing an additional 346 shares during the period. Curbstone Financial Management Corp lifted its position in Smith & Nephew by 1.9% during the 3rd quarter. Curbstone Financial Management Corp now owns 33,000 shares of the medical equipment provider’s stock valued at $1,290,000 after purchasing an additional 600 shares during the period. Finally, Capital Asset Advisory Services LLC raised its position in shares of Smith & Nephew by 8.5% in the 2nd quarter. Capital Asset Advisory Services LLC now owns 7,761 shares of the medical equipment provider’s stock valued at $317,000 after acquiring an additional 607 shares during the period. Institutional investors own 9.12% of the company’s stock.

Shares of SNN traded down $0.56 during midday trading on Monday, reaching $37.92. 6,349 shares of the stock were exchanged, compared to its average volume of 610,644. Smith & Nephew plc has a twelve month low of $26.07 and a twelve month high of $52.26. The company has a quick ratio of 1.04, a current ratio of 2.18 and a debt-to-equity ratio of 0.50. The company has a market cap of $16.85 billion, a P/E ratio of 18.86, a PEG ratio of 5.62 and a beta of 0.56. The stock’s 50 day simple moving average is $39.31 and its 200 day simple moving average is $39.96.

The company also recently announced a Semi-Annual dividend, which will be paid on Wednesday, October 28th. Stockholders of record on Friday, October 2nd will be issued a dividend of $0.278 per share. This represents a dividend yield of 1.8%. The ex-dividend date is Thursday, October 1st. Smith & Nephew’s dividend payout ratio is currently 27.45%.

A number of analysts recently weighed in on SNN shares. BofA Securities upgraded shares of Smith & Nephew from a “neutral” rating to a “buy” rating in a research report on Wednesday, July 29th. Morgan Stanley reiterated an “overweight” rating on shares of Smith & Nephew in a research report on Thursday, July 30th. JPMorgan Chase & Co. reiterated a “neutral” rating on shares of Smith & Nephew in a research report on Thursday, July 30th. Bank of America upgraded shares of Smith & Nephew from a “neutral” rating to a “buy” rating in a research report on Wednesday, July 29th. Finally, Berenberg Bank reiterated a “buy” rating on shares of Smith & Nephew in a research report on Friday, July 31st. Three investment analysts have rated the stock with a sell rating, four have assigned a hold rating and five have assigned a buy rating to the company. Smith & Nephew has an average rating of “Hold” and a consensus price target of $48.00.

About Smith & Nephew

Smith & Nephew plc develops, manufactures, and sells medical devices worldwide. The company offers knee implant products for specialized knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures.

Featured Story: Why do analysts give a neutral rating?

Want to see what other hedge funds are holding SNN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Smith & Nephew plc (NYSE:SNN).

Institutional Ownership by Quarter for Smith & Nephew (NYSE:SNN)

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.